ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

AGL Angle Plc

18,75
0,25 (1,35%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Angle Plc AGL London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,25 1,35% 18,75 17:24:37
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
18,50 17,75 19,50 18,75 18,50
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
16/5/202421:09ALNCNewsTRADING UPDATES: Bens Creek considers administration; Nexxen..
16/5/202408:00UK RNSAngle PLC Study of ovarian cancer CTCs using Parsortix
03/5/202413:17ALNCNewsCORRECT: Angle shares up on assay development deal with..
03/5/202412:50ALNCNewsAngle shares up on assay development deal with AstraZenaca
03/5/202408:00UK RNSAngle PLC New commercial agreement with large pharma
24/4/202411:32ALNCNewsAngle shares jump on supplier agreement with with..
24/4/202408:00UK RNSAngle PLC New commercial agreement with AstraZeneca
22/4/202417:52ALNCNewsIN BRIEF: Angle granted patents in US and Europe for..
22/4/202408:00UK RNSAngle PLC US and EU patents for innovative CellKeep™ slide
08/4/202408:00UK RNSAngle PLC Parsortix HER2 assay showcased at AACR 2024
22/3/202408:00UK RNSAngle PLC Parsortix at European breast cancer conference
22/1/202419:03ALNCNewsIN BRIEF: Angle highlights supportive data for DNA analysis..
22/1/202408:00RNSNONAngle PLC Potential utility in precision oncology
10/1/202413:57UKREGAngle PLC Standard form for notification of major holdings
04/1/202413:19ALNCNewsAngle shares soar following "breakthrough" cancer..
04/1/202410:10DJNAngle PLC Shares Rise on Cancer Patient Blood Sample..
04/1/202408:00UKREGAngle PLC Breakthrough clinical results
02/1/202409:51ALNCNewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer..
02/1/202408:00UKREGAngle PLC Contract announcement with Eisai Inc.
11/12/202321:44ALNCNewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via..
11/12/202308:00RNSNONAngle PLC Parsortix unlocks opportunities for drug discovery
11/12/202308:00UKREGAngle PLC Broker Announcement
05/12/202312:50ALNCNewsIN BRIEF: Angle launches diagnostic kit at cancer symposium
05/12/202308:00RNSNONAngle PLC ANGLE launches Portrait+ CTC kit at SABCS
09/11/202315:29ALNCNewsAngle says build up of revenue slower than hoped; launches..
09/11/202308:00RNSNONAngle PLC Launch of PD-L1 test to support cancer studies
09/11/202308:00UKREGAngle PLC Trading and business update
25/10/202318:28ALNCNewsTRADING UPDATES: Franchise Brands trading in line; Tribe..
25/10/202308:00RNSNONAngle PLC Supporting characterisation of CTCs in HNSCC
03/10/202314:02ALNCNewsAngle hails study which shows Parsortix outperforming lab..
03/10/202308:00RNSNONAngle PLC Parsortix outperforms standard for DTC harvest
29/9/202308:00RNSNONAngle PLC Parsortix system showcased at ACTC conference
07/9/202315:41ALNCNewsEARNINGS UPDATES: Sylvania beats production goal, Angle..
07/9/202308:00UKREGAngle PLC Interim Results for the period ended 30 June 2023
04/9/202315:21ALNCNewsAngle launches tumour cell assay to "unlock" customised..
04/9/202308:00RNSNONAngle PLC ANGLE launch of Portrait Flex assay
15/8/202308:00UKREGAngle PLC ANGLE notice of interim results
28/6/202317:54UKREGAngle PLC Result of 2023 Annual General Meeting
27/6/202313:24UKREGAngle PLC Standard form for notification of major holdings
05/6/202313:26ALNCNewsIN BRIEF: Angle hires Swansiger as new COO and Miller as new..
05/6/202308:00RNSNONAngle PLC ANGLE announces senior management appointments

Dernières Valeurs Consultées

Delayed Upgrade Clock